SCHEMBL360826

SCHEMBL360826

CN(CCCOc1cccc([N+](=O)[O-])c1C#N)C(=O)OC(C)(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
HTT P42858 1/20 0.42
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38
RECQL P46063 2/20 0.38
KDM4E B2RXH2 3/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C19 P33261 1/20 0.36
GAA P10253 1/20 0.35
KMT2A Q03164 5/20 0.35
MEN1 O00255 2/20 0.35
MAPT P10636 1/20 0.35
MAPK1 P28482 1/20 0.35
BCHE P06276 1/20 0.35
ACHE P22303 1/20 0.35
AURKA O14965 1/20 0.34
RPS6KB1 P23443 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL361888 0.80 CA12 (0.46) ALDH1A1HTTNPC1RAB9ARECQL
SCHEMBL11445653 0.79 KDM4E (0.48) ALDH1A1NPC1RAB9ARECQLKDM4E
SCHEMBL621587 0.79 CA12 (0.47) ALDH1A1HTTL3MBTL1KMT2AMEN1
SCHEMBL362429 0.78 CYP19A1 (0.38) ALDH1A1RAB9ARECQLGAAMAPT
SCHEMBL2419818 0.78 ALDH1A1 (0.43) ALDH1A1HTTNPC1RAB9ARECQL
SCHEMBL2417572 0.77 NPC1 (0.46) ALDH1A1HTTNPC1RAB9ARECQL
SCHEMBL17668972 0.77 ALDH1A1 (0.56) ALDH1A1HTTNPC1RAB9ARECQL
SCHEMBL15990162 0.77 ALDH1A1 (0.43) ALDH1A1HTTNPC1RAB9ARECQL
SCHEMBL2418012 0.76 RAB9A (0.50) ALDH1A1HTTNPC1RAB9ARECQL
SCHEMBL2419186 0.76 NPC1 (0.50) ALDH1A1HTTNPC1RAB9ARECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593461-A1 COMPOUNDS FOR THE REDUCTION OF BETA-AMYLOID PRODUCTION Bristol-Myers Squibb Company (US) 2013-05-22 EP disclosed
WO-2012009309-A1 COMPOUNDS FOR THE REDUCTION OF BETA-AMYLOID PRODUCTION BRISTOL-MYERS SQUIBB COMPANY (US) 2012-01-19 WO disclosed